We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

55 hedge funds and large institutions have $219M invested in Whitehawk Therapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

20% more funds holding

Funds holding: 46 → 55 (+9)

2.48% more ownership

Funds ownership: 58.37% → 60.85% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

26% less capital invested

Capital invested by funds: $294M → $219M (-$75.1M)

Holders
55
Holders Change
+9
Holders Change %
+19.57%
% of All Funds
0.87%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
16
Reduced
9
Closed
7
Calls
$1.85M
Puts
–
Net Calls
+$1.85M
Net Calls Change
+$1.85M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$4.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.05M
3
Millennium Management
Millennium Management
New York
+$3.85M
4
EP
Eversept Partners
New York
+$2.89M
5
RCMC
RK Capital Management (Colorado)
Colorado
+$1.84M

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$13M
2
VC
Vivo Capital
California
-$10.2M
3
O
OrbiMed
New York
-$3.08M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.4M
5
HS
HighVista Strategies
Massachusetts
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$961K +$625K +32,590 +135%
ECM
27
ExodusPoint Capital Management
New York
$745K +$841K +43,872 New
Rafferty Asset Management
28
Rafferty Asset Management
New York
$692K +$245K +12,790 +46%
Jane Street
29
Jane Street
New York
$683K +$771K +40,233 New
Northern Trust
30
Northern Trust
Illinois
$615K -$10.5K -550 -1%
Morgan Stanley
31
Morgan Stanley
New York
$608K +$635K +33,127 +1,231%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$590K – – –
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$463K +$514K +26,827 New
AICPI
34
ABG Innovation Capital Partners III
Hong Kong
$453K – – –
Citigroup
35
Citigroup
New York
$441K -$195K -10,177 -28%
BFM
36
Boothbay Fund Management
New York
$427K +$596K +31,088 +125%
AA
37
ALPS Advisors
Colorado
$364K -$51.8K -2,705 -11%
Squarepoint
38
Squarepoint
New York
$346K +$391K +20,416 New
LP
39
LMR Partners
United Kingdom
$315K +$356K +18,582 New
6CM
40
683 Capital Management
New York
$306K – – –
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
$294K +$332K +17,333 New
CSS
42
Cubist Systematic Strategies
Connecticut
$218K +$35.5K +1,851 +17%
SM
43
Sciencast Management
New Jersey
$201K +$221K +11,513 New
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
$199K +$224K +11,705 New
Bank of New York Mellon
45
Bank of New York Mellon
New York
$192K – – –
PA
46
Parallel Advisors
California
$111K – – –
US Bancorp
47
US Bancorp
Minnesota
$57K – – –
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$49K +$55.1K +2,876 New
TRCT
49
Tower Research Capital (TRC)
New York
$25K +$24.5K +1,277 +751%
Wells Fargo
50
Wells Fargo
California
$18K +$5.71K +298 +38%
1
2
3

WHWK Hedge Fund Activity: Q1 2022 in Review

55 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q1 2022, worth a combined $219M — down 26% from $294M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new WHWK positions and 7 closed out — a net gain of 9 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was State Street, adding an estimated $4.3M. The largest seller was Rock Springs Capital Management, exiting entirely with an estimated $13M sold.

  • 55 institutional investors held Whitehawk Therapeutics (WHWK) as of Q1 2022, up from 46 in Q4 2021.
  • Funds reported $219M of Whitehawk Therapeutics stock for Q1 2022, down 26% quarter-over-quarter.
  • 16 funds opened new Whitehawk Therapeutics positions in Q1 2022 and 7 closed out, a net change of +9 holders.
  • The largest Whitehawk Therapeutics buyer in Q1 2022 was State Street, an estimated $4.3M added.
  • The largest Whitehawk Therapeutics seller in Q1 2022 was Rock Springs Capital Management, an estimated $13M sold.

Based on aggregated 13F filings for Q1 2022.